Jinxin Zheng

Shanghai Jiao Tong University

H指数:26

被引数:2,104

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Global, Regional, and National Burden of Neonatal Encephalopathy due to Birth Asphyxia and Trauma, Its Attributable Risk Factors, 1990-2021: Results from the Global Burden of Disease Study 2021

NEUROEPIDEMIOLOGY

IF4

2025-10-010

PRE

Global burden, inequalities, frontier dynamics, and risk factors of sudden infant death syndrome, 1990-2021: a systematic analysis from the global burden of disease study 2021

全球负担、不平等性、前沿动态及危险因素：1990-2021年婴儿猝死综合征的全球疾病负担研究2021系统分析

TRANSLATIONAL PEDIATRICS

IF1.7

2025-10-010

PRE

The burden of mental disorders, substance use disorders, and self-harm among youths globally: findings from the 2021 Global Burden of Disease study

全球青年中精神障碍、物质使用障碍和自残行为负担：2021年全球疾病负担研究的结果

Translational Psychiatry

IF6.2

2025-09-290

OAAI

Global, regional, and national temporal trend and patterns of change in the burden of leishmaniasis from 1990 to 2021: an analysis of the Global Burden of Disease Study 2021

全球、区域和国家层面利什曼病负担的时序趋势及变化模式（1990年至2021年）：一项基于全球疾病负担研究2021的分析

SCIENCE IN ONE HEALTH

IF0

2025-09-010

OAAI

Deciphering the climate-malaria nexus: A machine learning approach in rural southeastern Tanzania

PUBLIC HEALTH

IF3.2

2025-01-010

PRE

Schistosomiasis transmission in Zimbabwe: Modelling based on machine learning

津巴布韦的血吸虫病传播: 基于机器学习的建模

INFECTIOUS DISEASE MODELLING

IF2.5

2024-12-011

OAAI

Loratadine Derivative Lo-7: A Weapon against Drug-Resistant Enterococcus and Streptococcal Infections

ACS INFECTIOUS DISEASES

IF3.8

2024-07-270

PRE

Baohuoside I inhibits virulence of multidrug-resistant Staphylococcus aureus by targeting the transcription Staphylococcus accessory regulator factor SarZ

宝霍苷 ⅰ 靶向转录葡萄球菌辅助调节因子SarZ抑制多药耐药金黄色葡萄球菌的毒力

PHYTOMEDICINE

IF8.3

2024-07-010

OAAI

AMXT-1501 targets membrane phospholipids against Gram-positive and -negative multidrug-resistant bacteria

EMERGING MICROBES & INFECTIONS

IF7.5

2024-02-295

OAAI

Optimized strategy for schistosomiasis elimination: results from marginal benefit modeling

PARASITES & VECTORS

IF3.5

2023-11-151

OAAI

The antimicrobial activity of cethromycin against Staphylococcus aureus and compared with erythromycin and telithromycin

BMC MICROBIOLOGY

IF4.2

2023-04-204

OAAI

Inhibition of planktonic growth and biofilm formation of Staphylococcus aureus by entrectinib through disrupting the cell membrane

entrectinib通过破坏细胞膜抑制金黄色葡萄球菌的浮游生长和生物膜形成

FRONTIERS IN MICROBIOLOGY

IF4.5

2023-01-090

OAAI

In vitro activities of licochalcone A against planktonic cells and biofilm of Enterococcus faecalis

FRONTIERS IN MICROBIOLOGY

IF4.5

2022-10-2115

OAAI

Clemastine Inhibits the Biofilm and Hemolytic of Staphylococcus aureus through the GdpP Protein

MICROBIOLOGY SPECTRUM

IF3.8

2022-04-2713

OAAI

Lapatinib Acts against Biofilm Formation and the Hemolytic Activity of Staphylococcus aureus

ACS OMEGA

IF4.3

2022-03-0312

OAAI

The Mechanism of Action of Ginkgolic Acid (15:1) against Gram-Positive Bacteria Involves Cross Talk with Iron Homeostasis

MICROBIOLOGY SPECTRUM

IF3.8

2022-02-2318

OAAI

In vitro activities of thiazolidione derivatives combined with daptomycin against clinical Enterococcus faecium strains

BMC MICROBIOLOGY

IF4.2

2022-01-073

OAAI

Selection and Identification of Novel Antibacterial Agents against Planktonic Growth and Biofilm Formation of Enterococcus faecalis

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2021-10-1611

PREAI

Diclazuril Inhibits Biofilm Formation and Hemolysis of Staphylococcus aureus

ACS INFECTIOUS DISEASES

IF3.8

2021-05-2123

PREAI

In Vitro Activity of the Novel Tetracyclines, Tigecycline, Eravacycline, and Omadacycline, Against Moraxella catarrhalis

ANNALS OF LABORATORY MEDICINE

IF3.9

2021-05-017

OAAI

Jinxin Zheng

个人简介

教育背景

工作经历

荣誉奖项

研究方向